New Enhanced Kinase Knowledgebase Released

San Diego, CA (June 20, 2007) –Eidogen-Sertanty has announced the next quarterly release of its Kinase Knowledgebase (KKB) with the addition of over 30K new data points and support for two new Oracle database cartridges.

Eidogen-Sertanty's KKB is the highest-quality kinase knowledgebase available containing biological activity data, structure-activity relationships (SAR), and chemical synthesis data surrounding protein kinases - one of the most therapeutically important classes of drug targets. The KKB now contains over 283,000 SAR data points spanning over 360 kinase targets curated from over 3100 journal articles and patents. The overall number of unique small molecule structures in the KKB is now greater than 440,000. 

With this release, new support for Elsevier MDL's Iscentris® Direct 6.0 cartridge and Accelrys' Accord Chemistry Cartridge is available. In addition, new structure-activity ASCII exports with example Pipeline Pilot® protocols to extract and build target-specific QSAR models are available for download.

For more information about the Kinase Knowledgebase, please visit the Kinase Knowledgebase Product Description page.

About Eidogen-Sertanty, Inc.
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations.  Eidogen-Sertanty’s unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization.  To find out more about Eidogen-Sertanty and their products and services please visit www.eidogen-sertanty.com.

Contact Information:
Steve Muskal
760-729-0211
pr@eidogen-sertanty.com